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The development of a vaccine against genital chlamydia in women is advancing, and the
evaluation of in situ immune responses following vaccination and challenge infections
is crucial for development of a safe and protective vaccine. This study employs the
sexually mature minipig model to characterize the genital in situ immune response
to Chlamydia trachomatis infection in pigs previously immunized intramuscularly with
UV-inactivated C. trachomatis serovar D (UV-SvD) adjuvanted/formulated with CAF01
adjuvant compared to a CAF01-alone control group. Pigs immunized with UV-SvD
were significantly protected against vaginal challenge with C. trachomatis on day 3
post inoculation and showed significantly higher cervical infiltrations of approximately
equal numbers of CD4+ and CD8+ T-cells, and IgG+ and IgA+ plasma cells compared
to adjuvant-alone immunized controls. These immunological signatures correspond
to findings in mice and are similar to those described in female chlamydia patients.
This proves important potential for the pig model in elucidating immunological in situ
signatures in future translational research in chlamydia vaccinology.
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INTRODUCTION
Chlamydia trachomatis is one of the most common sexually
transmitted bacteria in the world, causing infertility due to
development of chronic lesions in the upper genital tract
(Haggerty et al., 2010). Research into its pathogenesis and
to identify preventive strategies has been ongoing for many
years, primarily in murine and guinea pig models (Rank and
Whittum-Hudson, 1994; Maxion et al., 2004; O’Meara et al.,
2014). However, while murine models in several aspects are very
useful, mice have important differences in their immune system
compared to humans making interpretation of immunogenicity
and pathophysiology challenging (Meurens et al., 2012; De Clercq
et al., 2013; Lorenzen et al., 2015b). Nonhuman primates (NHPs)
are in general more comparable to humans than mice and
have been used in immunogenicity studies with C. trachomatis
serotypes. However, working with NHPs is associated with
high costs and ethical restrictions (Bell et al., 2011; De Clercq
et al., 2013). Pigs are increasingly being used for biomedical
research, as their size, anatomy, physiology and immunology
in many ways are comparable to those of humans (Fairbairn
et al., 2011; Dawson, 2012; Meurens et al., 2012; Lorenzen et al.,
2015b; Käser et al., 2017). Prepubertal pigs have previously been
used to study genital chlamydial infection (Vanrompay et al.,
2005; Schautteet et al., 2011b). However, the genital tracts of
prepubertal and sexually mature pigs differ in size, epithelial
thickness, vascularization, immune cell infiltration and hormone
fluctuations (Dyck and Swierstra, 1983; Hickey et al., 2011;
Lorenzen et al., 2015b, 2016) and the use of sexually mature
pigs as models should replicate events occurring in women
more closely.
Traditionally, vaccine immunogenicity and efficacy are
evaluated by systemic/mucosal immune responses through
e.g., flow cytometry and enzyme-linked immunosorbent
assays and the level of microorganisms and/or absence of
pathology, respectively. Histopathological evaluation, however,
can reveal detailed information on how the local in situ
immune responses are localized and if pathological changes
are present. Such responses are particularly important for
diseases of the genital tract, where an exacerbated response
in the oviducts can cause infertility, whereas a strong
local immune reaction in the cervix might be protective
(Paavonen and Eggert-Kruse, 1999; Maldonado et al., 2014).
Furthermore, the formation of memory lymphocyte clusters
in the genital tract is implied to be crucial for chlamydia
protection (Morrison and Morrison, 2000; Johnson and
Brunham, 2016; Johnson et al., 2018), adding further
arguments/motivation to perform immunohistochemical
(IHC) analysis on genital tract tissues when evaluating potential
chlamydia vaccines.
In this study, we investigate how immunization with
whole UV-inactivated C. trachomatis serovar D bacteria (UV-
SvD) adjuvanted with CAF01 compared to CAF01 alone,
influences the genital in situ lymphocyte response to genital
C. trachomatis infection. The detailed aim of the study
was to evaluate and identify potential in situ immune cell
signatures that may correlate with protection against chlamydial
infection in the sexually mature minipig model of genital
C. trachomatis infection.
MATERIALS AND METHODS
Chlamydia trachomatis
Chlamydia trachomatis SvD (Trachoma type D strain UW-3/Cx,
ATCC VR-885TM) was propagated in HeLa cells, harvested and
purified essentially as previously described (Olsen et al., 2006).
Inactivation of bacteria was achieved by exposing the bacterial
solution to UV light at a distance of 5 cm for 3 h (Lu et al., 2002)
and verification of the inactivation of infectivity was performed
by inoculating the bacterial suspension onto McCoy cells and
confirming the absence of inclusion forming units (IFU). The
total protein content of the inactivated bacterial suspension was
quantified by the bicinchoninic acid (BCA) method, as described
in the Micro BCATM Protein Assay Kit (cat no 23235, Thermo
Scientific) and used to adjust the concentration of the bacterial
suspension for intramuscular immunization.
Adjuvant and Vaccine Preparation
The adjuvant CAF01, a cationic liposome-based adjuvant,
consisting of 500 µg glycolipid trehalose 6,6′-dibehenate (TDB)
and 2500 µg dimethyldioctadecylammonium bromide (DDA),
was prepared as described elsewhere (Hansen et al., 2008). UV-
SvD bacteria were diluted in Tris–buffer (10 mM, pH 7.4) and
mixed with the adjuvant (1:1), using sterile procedures.
Experimental Animals
Sexually mature, 5–6 months-old female specific pathogen free
Göttingen minipigs (Ellegaard Minipigs, Sorø, Denmark) were
housed in the laboratory animal facilities at the Faculty of Health
and Medical Sciences, University of Copenhagen, in groups of
a maximum of five animals, were fed twice daily with standard
minipig diet and had access to water ad libitum. Some of the pigs
also served as control animals in another study (Bøje et al., 2015).
Immunization, Infection Challenge and
Sampling in vivo
The study was performed as two separate experiments due to
logistics, with 4–5 pigs/group in each experiment. The pigs were
intramuscularly immunized with 125 ug UV-SvD in CAF01
adjuvant (UV-SvD/CAF01) (n = 8) or with the adjuvant alone,
(CAF01) (n = 9), as a control group, twice with an interval of 2–3
weeks (Table 1). Following the immunization the pigs were estrus
synchronized with Regumate Equine R© (MSD Animal Health,
Ballerup, Denmark) and 3–4 weeks after the last immunization,
the animals were anesthetized during estrus with a Zoletil R© 50-
mixture as described by (Lorenzen et al., 2015a), and inoculated
deep intravaginally with 4 × 109 IFU C. trachomatis SvD in
5 ml 250 mmol/l sucrose, 10 mmol/l NaH2PO4, and 5 mmol/l
L-glutamic acid (SPG) using an insemination catheter (Osiris,
E-vet, Denmark). The rear aspect of each inoculated pig was
slightly elevated for 20 min post inoculation (pi) to reduce reflux
of inoculum.
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TABLE 1 | Experimental design.
No of pigs Immunization group Timepoint
Week 0 Week 2–3 Week 5–7
Day 0 pi Day 12 or 14 pi
9 CAF01
Immunization 1 Immunization 2 Vaginal inoculation Euthanasia
8 125 µg UV-SvD/CAF01
Sexually mature female minipigs were immunized twice with either adjuvant alone (CAF01, n = 9) or UV-inactivated C. trachomatis SvD together with CAF01 (UV-
SvD/CAF01, n = 8). Three to four weeks after the last immunization, the pigs were vaginally inoculated with 4 × 109 IFU C. trachomatis SvD during estrus, and samples
for histological analysis were obtained following euthanasia at day 12 or 14 pi.
The pigs were clinically monitored and had their rectal
temperature taken every second day in the post inoculation
period: animals with body temperatures exceeding 39.5◦C were
considered pyrexic. Any changes in behavior, appetite, urination,
defecation, vulval appearance or vaginal discharge were recorded.
Vaginal swabs were taken prior to inoculation and at
euthanasia (week 2 pi) to monitor the level of mucosal
antibodies and presence of C. trachomatis in the pi period.
For antigen detection, additional vaginal swabs were taken
on day 3 pi and week 1 pi as well. The swabs were
immediately placed in 1 ml SPG and kept on ice until
further handling. Three glass beads were added to each sample
tube, and the samples were whirl mixed for 1 min, where
after the swab material was aliquoted and stored at -80◦C
until further analysis. Blood samples were taken prior to
inoculation and at 2 weeks pi, from the jugular vein in heparin-
stabilized tubes for cell isolation and plain tubes for serum
isolation. The plain tubes were centrifuged for 15 min at
2400 g, and serum was isolated and kept at −20◦C until
further handling.
q-PCR Detection of C. trachomatis
The vaginal swabs for q-PCR detection were treated slightly
differently in the two separate experiments, however, all
samples from day 3 pi were treated similarly: DNA extraction
was performed with Chelex R©100 (Bio-Rad, Life Science,
Denmark) and real-time q-PCR detection of C. trachomatis
was performed by detection of the 16S rRNA gene as described
in (Bøje et al., 2015; Erneholm et al., 2016). Based on the
negative control, the Ct cut-off for true positive samples was
determined to be 37.
Measurement of C. trachomatis Specific
Antibodies in Serum and in Vaginal
Swabs
Determination of antigen-specific antibodies in serum and
vaginal swabs was carried out using an indirect ELISA coating
with UV-inactivated C. trachomatis SvD (4 µg/ml) as described
previously (Erneholm et al., 2016). Confirmed positive serum
from a previous study was included as a positive control and
used as an internal standard to correct for plate-to-plate variation.
Results are presented as corrected OD values, calculated as
the increase in OD-value on day 14 pi compared to day 0 pi
(corrected ODday14pi = ODday14pi – ODday 0pi).
IFN-γ Response From in vitro Stimulated
PBMCs and Lymph Node Cells
Peripheral blood mononuclear cells (PBMC) and lymph node
cells were isolated and stimulated with UV-SvD (10 µg/ml),
medium alone and staphylococcal enterotoxin B (1 µg/ml).
After 3 days of incubation at 37◦C with 5% CO2, cell culture
supernatants were harvested and stored at −20◦C until further
analysis. The amounts of IFN-γ in cell culture supernatants were
determined by a sandwich ELISA as described in (Bøje et al.,
2015; Lorenzen et al., 2015a).
Necropsy
At 12 or 14 days pi, the pigs were anesthetized and euthanized
by exsanguination. At necropsy, all abdominal and thoracic
organs were assessed for gross lesions. Samples from the vagina,
cervix, uterine horns, and oviducts were fixed in 10% neutral
buffered formalin and parallel samples were placed in cryostat
embedding media (Tissue-Tek R© O.C.T., WVR) snap-frozen in ice
cold petroleum, and stored at−80◦C.
Tissue Handling and Histology
The formalin fixed tissue was transferred to 70% ethanol after
48 h of fixation, processed routinely and embedded in paraffin.
Sections of 3–4 µm were cut, mounted on SuperFrost R©/Plus
glass slides (Hounisen, Denmark), deparaffinized and rehydrated
according to standard protocols and stained with hematoxylin
and eosin (HE).
The histological slides were blinded, randomized and
evaluated by the same observer. Infiltrations of lymphocytes,
plasma cells and neutrophils in the vaginal, cervical and uterine
mucosa were scored using a multiparametric semi-quantitative
scoring system ranging from 0 to 4: 0: no/single cells, 1:
scattered cells, 2: moderate numbers of cells, and/or few,
small cell accumulations, 3: large numbers of cells, and/or
multiple cell accumulations, 4: excessive numbers of cells,
coalescing accumulations. Perivascular lymphocytic infiltrations
were similarly scored from 0 to 3; 0: no infiltration, 1: mild
infiltration/single vessel, 2: moderate infiltration/multiple vessels,
3: extensive infiltration, multiple vessels. Regarding the uterine
horns, a mean value of each parameter for left and right horns was
calculated. For statistical analysis, the scores for “lymphocytes”
and “perivascular lymphocyte infiltration” were added for each
sample. Presence of edema, degenerated epithelium, and luminal
content were also recorded.
Frontiers in Microbiology | www.frontiersin.org 3 February 2019 | Volume 10 | Article 197
fmicb-10-00197 February 7, 2019 Time: 0:41 # 4
Erneholm et al. Chlamydia Genital Immune Cell Signatures
The frozen tissues were cut on a cryostat, fixed in ice cold
acetone for 20 min and air dried. The sections were kept at−20◦C
until further handling.
Histochemical and
Immunohistochemical Staining
Representative histosections were selected for visualization of
plasma cells, T cells and T cell subsets. For visualization of plasma
cells, the slides were incubated in methyl green pyronin solution
(MGP) (Sigma-Aldrich) for 10 min, rinsed in distilled water, and
air dried and mounted in xylene.
For visualization of T cells (CD3+), helper T cells (CD4+), and
cytolytic T cells (CD8+), as well as isotype-specific plasma cells
through membrane-bound IgA and IgG, immunohistochemistry
was performed, see Table 2 for details. The anti-CD8 antibody
used binds the b epitope of the CD8α chain. In pigs, CD8α
is constitutively expressed on cytolytic T cells and expressed
upon antigen activation of CD4 and γδ T cells (Gerner et al.,
2009). Blocking and incubation steps were performed according
to the manufacturers’ recommendations. A negative control
was included using a non-sense antibody (goat serum for
IgA and IgG, isotype specific IgG for CD3 (mouse IgG1,
Clone P3.6.2.8.1, eBioscience), CD4 (mouse IgG2b, clone MPC-
11, BD Pharmingen) and CD8 (mouse IgG2a, clone C1.18.4,
BD Pharmingen). In addition, positive control sections were
included. The complete list of antibodies used for IHC is included
in Table 2.
Statistics
Statistical analyses were carried out using Graph Pad Prism 5.
The Mann-Whitney test was used to analyze differences between
the groups. P < 0.05 was considered statistically significant. The
following symbols were used to designate significance: ∗P 0.01 to
0.05, ∗∗P 0.01–0.001, ∗∗∗P < 0.001.
Ethics Statement
This study was carried out in accordance with the
recommendations of the EU Directive 2010/63, Danish
Animal Experiments Inspectorate of the Danish Veterinary
and Food Administration. The protocol was approved by the
Danish Animal Experiments Inspectorate with license no:
2008/561-1581.
RESULTS
Chlamydia trachomatis Infectious Load
Following Inoculation
Pigs were intramuscularly immunized with 125 ug UV-SvD
in CAF01 (UV-SvD/CAF01) (n = 8) and the control group
was administered adjuvant alone (CAF01) (n = 9) by the
intramuscular route. The animals were challenged during estrus
by deep vaginal inoculation with 4× 109 IFU C. trachomatis SvD
and all pigs remained clinically unaffected throughout the study.
Following vaginal challenge, infectious load was determined
in vaginal swabs by q-PCR, detecting C. trachomatis 16S
rRNA genes. The immunization with UV-SvD/CAF01 induced
protection in terms of a significantly lower vaginal bacterial load
on day 3 pi in the UV-SvD/CAF01 group, compared to the
control/CAF01 group (Figure 1). On the next sampling day (i.e.,
day 7 pi), only 2 out of 9 animals in the CAF01 group and 1 out
of 8 animals in the UV-SvD/CAF01 group had detectable levels
of vaginal C. trachomatis by q-PCR. On the following sampling
(days 12 or 14 pi) 1 out of 9 animals in the CAF01 group and
2 animals in the UV-SvD/CAF01 group had detectable levels of
vaginal C. trachomatis (Supplementary 1).
FIGURE 1 | Chlamydia trachomatis q-PCR detection in vaginal swabs.
Detection of C. trachomatis (Ct) in vaginal swabs by q-PCR on day 3 pi. Each
dot represents one animal. The gray bar shows median. Statistics:
Mann-Whitney test. Two asterisks (∗∗) indicate a P value between 0.01–0.001.
TABLE 2 | Overview of immunohistochemical antibodies and reagents.
Target antigen Manufacturer Dilution and incubation of primary antibody Detection method and chromogen
Formalin fixed tissue
Mouse anti-pig CD3 Southern Biotech Clone PPT3 1:1000 o/n 4 ◦C Ultravision One DABa
Goat anti-pig IgA Nordic Biosite Lot no: A100-102A-16 1:4000 1 h RT Vectastain Elite-ABC – Goat AECb
Goat anti-pig IgG Nordic Biosite Lot no: A100-104A-12 1: 7000 1 h RT Vectastain Elite-ABC – Goat AECb
Frozen tissue
Mouse anti-pig CD4 Southern Biotech Clone 74-12-4 1:500 1 h RT Ultravision AEC
Mouse anti-pig CD8α BD Pharmingen Clone 295/33-25 1:500 1 h RT Ultravision AEC
All formalin fixed tissue was exposed to antigen retrieval by microwave boiling in aTEG buffer pH 9.0 for 2 × 5 min, bCitrate buffer pH 6.0 for 5 min, and blocked for
endogenous peroxidase in a solution of hydrogen peroxide (0.6%) for 15 min. RT = room temperature.
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Necropsy and Histopathological
Examination of the Genital Tract
At necropsy, congestion was observed in the broad ligament
of the uterus in pigs of both groups. In all animals, the
uterine mucosa was edematous and slightly congested, and
the ileosacral lymphocentrum was slightly enlarged. Pigs in
the UV-SvD/CAF01 group had significantly greater infiltration
of lymphocytes in the mucosa of the uterus (p = 0.0021),
cervix (p = 0.0002), and vagina (p = 0.01) relative to the
CAF01 group (Figures 2C,F,I). The lymphocytes were typically
observed in moderate numbers, localized subepithelially, either
scattered in the stroma, or aggregated in follicles (Figure 2). In
the UV-SvD/CAF01 group, the lymphocytes were also located
perivascularly in the mucosa (Figure 2B, arrow). Intraepithelial
lymphocytes were found to a lesser extent in both groups
(Figure 2E, arrowheads). A significantly denser infiltration of
plasma cells was present in the cervix of the UV-SvD/CAF01
group, compared to the control group (Figure 2E insert, and
Supplementary 2). The plasma cells were typically located
in subepithelial clusters, intermingled with lymphocytes, and
diffusely scattered in the subepithelial stroma. Neutrophils were
noted in low numbers in the epithelium and subepithelial stroma
of the vagina and cervix, in both groups (Figures 2A–E). Mild
to moderate hydropic degeneration and cytoplasmic vacuolation,
was a feature of the vaginal and cervical epithelium of both
groups (Figure 2E, arrowheads), with accompanying mild
to moderate intraepithelial microabcessation. The severity of
epithelial degeneration was slightly greater in the cervix than in
the vagina in both groups; however, no differences were found
between the two groups. Lesions were not found in the oviducts
of either groups.
Characterization of Leukocyte Infiltration
To further analyze the leukocyte infiltration in the lower
genital tract, representative sections were selected and stained
immunohistochemically with anti-CD3 for detection of T
cells, and with MGP to confirm the presence of plasma
cells. As visualized in Figure 3, the cell accumulations in
the stroma were to a large extent made up of CD3+ cells,
particularly in the UV-SvD/CAF01 group, where these cells
were most dense (Figure 3B). CD3+ lymphocytes were
also found intraepithelially in the cervix and vagina of
both groups (Figures 3A,B, arrowheads). While plasma
cells were present in lower numbers compared to CD3+
cells, they were more of a prominent feature in the UV-
SvD/CAF01 group than in the CAF01-group (Supplementary 2).
Plasma cells were typically found in aggregates and in
more dispersed scattering in the sub-epithelial stroma.
For further characterization of T cells and plasma cells,
IHC staining of CD4, CD8, IgA, and IgG were performed
in selected, representative, sections of the vagina, cervix
and uterus of both groups. In general, there were more
CD8+ T cells than CD4+ T helper lymphocytes in both
groups (Figures 3C–F). The overall distribution of CD4+
and CD8+ cells overlapped consistently with the CD3
staining, with the highest number of cells found in the
vagina and cervix of UV-SvD/CAF01 immunized pigs
(Figures 3A–F). These cells predominantly appeared as
accumulations in the subepithelial stroma (Figure 3). The
density of CD4+ and CD8+ cells was similar in these
accumulations (Supplementary 3). Whereas the CD4+
cells were almost only observed in the accumulations,
CD8+ cells also localized intraepithelially, with a multifocal
distribution, corresponding to the intraepithelial staining of
CD3 (Figures 3C–F).
The distribution of plasma cells was described in HE
and MGP stained sections, with moderate numbers of this
cell type infiltrating the vagina of both groups. A higher
density of plasma cells was detected in the cervix of the UV-
SvD/CAF01 group compared to the CAF01 group (Figures 4A–
E). There were more IgA+ cells relative to IgG+ cells in
the vagina and cervix of both groups. In the UV-SvD/CAF01
group, the IgA+ cells were scattered multifocally in the
subepithelial stroma (Figure 4B). IgG+ cells were almost
exclusively found within, or adjacent to, lymphoid follicles
(Figure 4E). Few IgA+ and IgG+ cells were found in the
uterine horns.
Chlamydia trachomatis Specific Immune
Responses Following Inoculation
The UV-SvD/CAF01 immunized pigs had significantly
higher Chlamydia-specific IgG levels in serum on the
day of infection (0 pi) (p = 0.0138) and on day 14 pi
(p = 0.0291), compared to the CAF01 group (Supplementary 4).
Furthermore, the UV-SvD/CAF01 immunized pigs had
significantly higher Chlamydia-specific IgG levels on the
vaginal surface on day 14 pi compared to the CAF01 control
group (p = 0.0286, Figure 4F) and similarly these animals
exhibited a significantly higher systemic IFN-γ response
from re-stimulated PBMCs on day 14 pi (Figure 3G,
p = 0.0079). In addition, the UV-SvD/CAF01 group also
showed significantly higher IFN-γ responses in cells
from the re-stimulated iliosacral lymph node at day 14 pi
(Figure 3H,p = 0.015).
DISCUSSION
The essential aim of this study was to evaluate and identify
potential in situ immune cell signatures that may correlate with
protection against chlamydial infection in the sexually mature
minipig model of genital C. trachomatis infection.
The genital in situ immune cell signature in the UV-
SvD/CAF01 vaccinated group, associated with the significant
protection on day 3 pi in this group, consisted of significant
infiltrations of plasma cells and T cells in the sub-epithelial
stroma of the lower genital tract, particularly in the cervical
stroma. The immune cells were present in a scattered distribution
as well as in sub-epithelial lymphoid follicles consisting of
approximate equal numbers of CD4+ and CD8+ T cells, along
with IgG+ and IgA+ plasma cells. While it is not a given that
these immune cells are C. trachomatis-specific, the IHC results
correlate well with the significant C. trachomatis-specific IFN-γ,
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FIGURE 2 | Histopathological changes including lymphocyte counts in the minipig vagina, cervix and uterus. The first and second column show representative
pictures from the CAF01 and the UV-SvD/CAF01 groups, respectively. Each row represents the different anatomical locations; the vagina, cervix and uterus. The
scale bar equals 200 µm. (A) In the vagina of the CAF01-group, there is a low number of lymphocytes scattered in the subepithelial stroma. (B) UV-SvD/CAF01
group, vagina. A profound perivascular infiltration of lymphocytes is noted (arrow), and also a subepithelial diffuse infiltration of lymphocytes (arrowheads). Blood
vessel marked with asterisk (∗) (C) Comparison of the semiquantitative lymphocyte infiltration scores, showing a significant difference in the lymphocyte score in the
vagina of the two groups. Each dot represents one animal. Bars show median. (D) CAF01-group, cervical tissue, where a small subepithelial lymphocyte infiltration is
extending into the epithelium (arrow) (E) In the cervix of the UV-SvD/CAF01 group, there is a dense subepithelial infiltration of lymphocytes (arrow) and plasma cells
(insert, arrow). Intraepithelial vacuoles (arrowheads) and lymphocytes are also noted (F) Comparison of the semiquantitative lymphocyte infiltration scores, showing a
highly significant difference in the lymphocyte score in the cervix of the two groups. Each dot represents one animal. Bars show median. (G) In the uterus, stromal
edema is found in the CAF01-group (H) In addition to stromal edema, multiple small perivascular lymphocytic accumulations (arrowheads) are seen in the
UV-SvD/CAF01 group. Blood vessel marked with asterisk (∗) (I) Comparison of the semiquantitative lymphocyte infiltration scores, showing a significant difference in
the lymphocyte score in the uterus of the two groups. Each dot represents one uterine horn. Bars show median. Statistics: Mann-Whitney test. Asterisks (∗) indicate
the level of significance: ∗P 0.01 to 0.05, ∗∗P 0.01–0.001, and ∗∗∗P < 0.001.
IgG and IgA responses (Figures 3, 4) suggesting that the IHC data
represent an in situ C. trachomatis-specific response.
The increased numbers of CD8+ T cells in the genital
tract is consistent with previously described resident CD8+
cells in the porcine uterine epithelium (Kaeoket et al.,
2001, 2002), which are analogous to intraepithelial T cells
in human cervical epithelium (Johansson et al., 1999).
Likewise, a larger proportion of CD8+ cells have been
found in infected NHPs (Van Voorhis et al., 1996) and
guinea pigs (Rank et al., 2000), whereas in mice, CD4+ T
cells have been found to dominate following vaccination
and Chlamydia challenge (Morrison and Morrison, 2000;
Johansson and Lycke, 2001). Importantly, the composition
of the cellular infiltrate in the pig model is similar to that
reported in human cases of chlamydial cervicitis, including
subepithelial inflammation with increased numbers of both
CD4+ and CD8+ T cells, plasma cells and lymphoid follicle
formation (Kiviat et al., 1990; Mittal et al., 2004; Ficarra
et al., 2008; Agrawal et al., 2009). Hence, immunized pigs
may mount an adaptive immune response in situ mimicking
reinfection in human patients with chlamydial cervicitis.
It should be noted that the anti-CD8 antibody used does
not differentiate CD8+ single positive cytolytic T cells and
antigen-activated CD8+/CD4+ double positive helper T
cells. In pigs 10–13% of the T cells can be CD8+/CD4+
double positive, hence a proportion of the identified CD8+
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FIGURE 3 | CD3+, CD4+, and CD8+ T cells in the cervix along with C. trachomatis specific PBMC IFN-γ responses. Representative sections from the cervix were
immunohistochemically (IHC) stained against CD3, CD4, and CD8α. All pictures and graphs are from day 14 pi. The left column shows the adjuvant (CAF01) control
group IHC stains, the middle column shows the UV-SvD/CAF01 IHC stains and the right column presents C. trachomatis specific immune responses in PBMCs (G)
and lymph nodes (H). CD3 (A,B): CD3+ cells (brown) were detected in all sections. (A) In the CAF01-group the CD3+ cells were mainly located intraepithelially
(arrows). (B) In the UV-SvD/CAF01 group, the CD3+ cells were typically accumulated in the subepithelial stroma (encircled), and occasionally also intraepithelially
(arrow). CD4 (C,D): CD4+ cells (staining red) were found in both groups, localized in subepithelial lymphoid accumulations (D, arrow), and occasionally in the
epithelium; however, to a larger degree in the UV-SvD/CAF01 group (D). CD8 (E,F): CD8+ cells were found both intraepithelially and subepithelially in both groups
(arrows), with a larger amount in the UV-SvD/CAF01 group, in a similar fashion to the CD4+ cells. In lymphoid accumulations, primarily present in the UV-SvD/CAF01
group, the density of CD4+ and CD8+ cells were approximate equal (also illustrated in supplementary 3). The right column shows C. trachomatis specific immune
responses. Each dot represents one animal. The gray bar shows the median (G) Systemic T-cell response: IFN-γ response from PBMCs re-stimulated with
C. trachomatis (H) T-cell response in the uterine draining lymph node: IFN-γ response from lymph node cells re-stimulated with C. trachomatis Statistics:
Mann-Whitney test. Asterisks (∗) indicate the level of significance: ∗P 0.01 to 0.05, ∗∗P 0.01–0.001, and ∗∗∗P < 0.001.
cells might be double positive (Gerner et al., 2009, 2015).
However, when comparing the distribution of CD4+ and
CD8+ positive cells (Supplementary 3) it is clear that the
intraepithelial T cells are predominantly CD8+ single positive
cytolytic T cells.
The finding of IgA+ and IgG+ plasma cells in the
genital tract following vaginal challenge upon intramuscular
immunizations is promising from the perspective of an
intramuscular immunization strategy, but contradicts to some
extent recent studies indicating that a mucosal/intranasal
booster immunization is needed to trigger significant IgA
(Lorenzen et al., 2015a; Christensen et al., 2017) and T
cell responses on the genital mucosa (Stary et al., 2015).
However, other studies in pigs have also shown protection
without the addition of a mucosal booster (Schautteet et al.,
2011a; Bøje et al., 2015). Clearly, the route of administration
influences the immune response (Rank et al., 1990; Lu
et al., 2002; Stary et al., 2015) and for both mucosal as
well as parenteral immunizations it is important to use the
optimal adjuvant/delivery system to direct the appropriate
immune response (Igietseme et al., 2011; Stary et al., 2015).
In a comparative study of five clinically tested adjuvants
for parenteral use (IC31 R©, CAF01, GLA-SE, MF59 R© and
Alum), Knudsen et al., 2016 demonstrated that CAF01 has
an immunological profile (Th1/Th17) tailored for Chlamydia.
Similarly, parenteral immunization with UV-EBs formulated in
the (Th1) AS01B adjuvant can elicit significant protection (Coler
et al., 2009). Future studies are required to elucidate the effect
of immunization routes/adjuvants and the relative impact of
effector T cells, genital IgA producing plasma cells and vaginal
IgG on bacterial clearance. In such studies, the immune cell
subsets could also be quantified.
An important perspective of evaluating in situ responses and
cell signatures is to be able to distinguish between protective and
aberrant cell mediated responses that cause oviduct pathology
(Paavonen and Eggert-Kruse, 1999; Maldonado et al., 2014).
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FIGURE 4 | IgG+ and IgA+ B cells in the cervix along with vaginal C. trachomatis specific IgA and IgG antibody responses. Representative sections from the cervix
were immunohistochemically (IHC) stained against IgA and IgG. All pictures and graphs are from day 14 pi. The left column shows the adjuvant (CAF01) control
group IHC stains, the middle column shows the UV-SvD/CAF01 IHC stains and the right column presents C. trachomatis specific immune responses in vaginal
swabs (C,F). The UV-SvD/CAF01 group (B,E) contained more plasma cells than the CAF01 group (A,D) (arrows). In general, the IgA+ cells were more abundant
than IgG+ cells. IgA+ cells were typically scattered in the subepithelial stroma (B, insert and arrows), whereas the lymphoid follicles had no, or very few IgA+ cells (B,
lymphoid follicle encircled). IgG+ cells were typically found exclusively inside, or adjacent to, cellular accumulations (E, lymphoid follicle marked and inserted). The
right column shows C. trachomatis specific immune responses. Each dot represents one animal. The gray bar shows the median (C) C. trachomatis specific IgA in
vaginal swabs. Representative data from one experiment. (F) C. trachomatis specific IgG in vaginal swabs. Representative data from one experiment. Asterisks (∗)
indicate the level of significance: ∗P 0.01 to 0.05, ∗∗P 0.01–0.001, and ∗∗∗P < 0.001.
In general, the vagina and especially the cervix function as
immune-inductive sites, with formation of mucosa-associated
lymphoid aggregates in response to local antigenic stimulation
(Pudney et al., 2005). This is normally a non-pathologic
response, protecting the genital tract from ascending infections
(Pudney et al., 2005). Tissue-resident T cells are crucial for
protective immunity in the genital tract, both against Chlamydia
(Igietseme and Rank, 1991; Johansson and Lycke, 2001; Olive
et al., 2011), and herpes simplex virus 2 (Iijima and Iwasaki,
2014). In fact it has recently been hypothesized that the
establishment of C. trachomatis-specific memory lymphocyte
clusters in the genital mucosa is crucial for protection against
chlamydia infection (Stary et al., 2015; Johnson and Brunham,
2016). Furthermore, the development of tertiary lymphoid
tissue at sites of inflammation has also been associated
with increased protection at other anatomical locations
exposed to microorganisms from the external environment
(Wiley et al., 2009).
In the current study, few histopathological changes were
observed in the uterine horns, and no lesions were found in
the oviducts. It is likely that the bacteria did not ascend to the
upper genital tract during this study, due to the short duration
of infection and long and complex nature of the porcine cervix as
discussed in (Lorenzen et al., 2015b). For true evaluation of upper
genital tract cell signatures and development of pathology, the
model should be optimized e.g., by inoculating directly into the
uterus as recently performed (Lorenzen et al., 2017). Nonetheless,
the observed inflammation in the porcine cervix is similar to
what occurs in human chlamydial cervicitis, representing most
of the human infections (Brunham and Rey-Ladino, 2005).
Only a small percentage of asymptomatic cervical chlamydia
infections are actually estimated to ascend the genital tract
(Haggerty et al., 2010).
The systemic immune response was also evaluated in the
present study, and the robust Chlamydia-specific antibody and
IFN-γ responses in the UV-SvD/CAF01 vaccinated animals were
consistent with previous studies with CAF01 (Agger et al., 2008)
and are also similar to responses to immunization with UV-
inactivated Chlamydia in guinea pigs (Rank et al., 1990) and mice
(Lu et al., 2002).
CONCLUSION
In conclusion, the significant protection of minipigs immunized
with UV-SvD/CAF01 was associated with significant infiltrations
of CD4+ and CD8+ T lymphocytes and IgA+ and IgG+ plasma
cells to the lower genital tract with the attendant formation of
intra-mucosal lymphoid follicles. These findings correspond to
the “immune cell signatures” that develop during chlamydial
cervicitis in women and highlight the potential use of this
experimental infection model for more detailed evaluation of
in situ responses during vaccine trials including its use in
distinguishing pathologic from protective responses.
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